Your search returned 3 results.

Results
	1.	Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption. [electronic resource] by Harrer, Ellen Bäuerle, Michael Ferstl, Barbara Chaplin, Paul Petzold, Barbara Mateo, Luis Handley, Amanda Tzatzaris, Maria Vollmar, Jens Bergmann, Silke Rittmaier, Marion Eismann, Kathrin Müller, Sandra Kalden, Joachim R Spriewald, Bernd Willbold, Dieter Harrer, Thomas Producer: 20050729 In: Antiviral therapy vol. 10 Availability: No items available. Save to lists Add to cart (remove)
	2.	BRAF inhibitor treatment in classic hairy cell leukemia: a long-term follow-up study of patients treated outside clinical trials. [electronic resource] by Liebers, Nora Roider, Tobias Bohn, Jan-Paul Haberbosch, Isabella Pircher, Andreas Ferstl, Barbara Ebnöther, Monika Wendtner, Clemens-Martin Dearden, Claire Follows, George A Ho, Anthony D Müller-Tidow, Carsten Dreger, Peter Troussard, Xavier Zenz, Thorsten Dietrich, Sascha Producer: 20200929 In: Leukemia vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1-2a trial. [electronic resource] by Raab, Marc S Engelhardt, Monika Blank, Antje Goldschmidt, Hartmut Agis, Hermine Blau, Igor W Einsele, Hermann Ferstl, Barbara Schub, Natalie Röllig, Christoph Weisel, Katja Winderlich, Mark Griese, Janine Härtle, Stefan Weirather, Johannes Jarutat, Tiantom Peschel, Christian Chatterjee, Manik Producer: 20200526 In: The Lancet. Haematology vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)